STOCK TITAN

Rocket Pharmaceuticals Warrant (RCKTW) Stock Price, News & Analysis

RCKTW

Rocket Pharmaceuticals Warrant (RCKTW) last traded on September 2, 2026. A Form 25-NSE filed on September 2, 2026 removes its shares from exchange listing.

Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
95 206 sessions, September 2, 2025 to September 2, 2026
Largest daily move
+1900% close of September 2, 2026
1-year change
-95% closing prices, September 2, 2025 to September 2, 2026
1-month change
+42.9% closing prices, July 31, 2026 to September 2, 2026

Company Description

Rocket Pharmaceuticals Warrant (RCKTW) is classified in the pharmaceutical preparations industry.

RCKTW declined 95.0% in the 12 months to September 2, 2026. The last closing price was $0.0020.

For FY2025, Rocket Pharmaceuticals Warrant reported revenue of $0 with net income of -$223.1M and diluted earnings per share of -$2.01.

This page collects what Stock Titan holds for RCKTW, including price data, SEC filings, financial highlights, and short interest trends.

Stock Performance

$0.0020
No recent trading
Last close: September 2, 2026
-95%
1 year to September 2, 2026

Rocket Pharmaceuticals Warrant (RCKTW) closed at $0.0020 on September 2, 2026. In the 12 months to September 2, 2026, the price lost 95.0%.

See what a $1,000 investment in RCKTW would be worth today

Average down calculator for RCKTW

RCKTW Metrics & Rankings

Price returns through September 2, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

No recent news available for RCKTW.

Financial Highlights

Rocket Pharmaceuticals Warrant reported operating income of -$231.7M in FY2025, and net income was -$223.1M. Diluted earnings per share stood at -$2.01. The company generated -$190.0M in operating cash flow. The current ratio was 6.38, measuring current assets divided by current liabilities.

$0
Revenue (FY2025)
-$223.1M
Net Income (FY2025)
-$190.0M
Operating Cash Flow

Upcoming Events

No upcoming events scheduled for RCKTW.

Short Interest History

Last 12 Months

Short interest in Rocket Pharmaceuticals Warrant (RCKTW) currently stands at 55.4 thousand shares, up 11.8% from the previous reporting period. Since November 2025, short interest has increased by 903.4%.

Days to Cover History

Last 12 Months

Days to cover for Rocket Pharmaceuticals Warrant (RCKTW) currently stands at 1.0 days, down 28.6% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has decreased by 73.9%. Across the settlements charted above, it has ranged from 1.0 to 29.8 days.

RCKTW Company Profile & Sector Positioning

Rocket Pharmaceuticals Warrant (RCKTW) .

Frequently Asked Questions

Rocket Pharmaceuticals Warrant (RCKTW) last traded on September 2, 2026. A Form 25-NSE filed on September 2, 2026 removes its shares from exchange listing.

Rocket Pharmaceuticals Warrant (RCKTW) has no recent trading. Its last close was $0.0020 on September 2, 2026.

The FY2025 revenue of Rocket Pharmaceuticals Warrant (RCKTW) is $0, from its most recent completed fiscal year.

The FY2025 net income of Rocket Pharmaceuticals Warrant (RCKTW) is -$223.1M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Rocket Pharmaceuticals Warrant (RCKTW) is -$2.01 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Rocket Pharmaceuticals Warrant (RCKTW) is -$190.0M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The current ratio of Rocket Pharmaceuticals Warrant (RCKTW), current assets divided by current liabilities, was 6.38 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The operating income of Rocket Pharmaceuticals Warrant (RCKTW) is -$231.7M for FY2025, its most recent completed fiscal year. Learn about operating income.